ethyl pyruvate has been researched along with Acute Disease in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
He, G; Liang, X; Shen, Y; Tan, G; Zhang, X | 1 |
Lei, C; Li, D; Liu, M; Wu, B; Zhang, S | 1 |
Ling, Y; Tao, J; Wang, CY; Wu, HS; Xiong, JX; Yang, ZY; Yin, T | 1 |
Guo, RX; Luan, ZG; Ma, XC; Zhang, C; Zhang, H | 3 |
Delude, RL; Fink, MP; Han, X; Yang, R | 1 |
Cheng, BQ; Fan, W; Jia, XQ; Li, WJ; Liu, CT; Zhang, SZ; Zhang, Y; Zhong, N | 1 |
Dou, KF; Sheng, ZY; Wang, Q; Wang, WJ; Wang, YB; Xian, LM; Yao, YM | 1 |
9 other study(ies) available for ethyl pyruvate and Acute Disease
Article | Year |
---|---|
Ethyl pyruvate ameliorate inflammatory response of sinonasal mucosa by inhibiting HMGB1 in rats with acute rhinosinusitis.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Formaldehyde; Gene Expression Regulation; HMGB1 Protein; Interleukin-6; Male; Nasal Mucosa; Polyvinyl Alcohol; Pyruvates; Rats; Rats, Sprague-Dawley; Rhinitis; Sinusitis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2021 |
Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage.
Topics: Acute Disease; Animals; Apoptosis; Benzamides; Brain; Brain Edema; Cerebral Hemorrhage; HMGB1 Protein; Inflammation; Interleukin-1beta; Male; Matrix Metalloproteinase 9; Pyruvates; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2015 |
Delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box 1 levels in rats.
Topics: Acute Disease; Alanine Transaminase; Animals; Aspartate Aminotransferases; Creatinine; Disease Models, Animal; HMGB1 Protein; Kaplan-Meier Estimate; Kidney; Liver; Lung; Male; Pancreatitis; Pyruvates; Rats; Rats, Wistar; Reperfusion Injury; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2008 |
Role of high-mobility group box 1 protein in the pathogenesis of intestinal barrier injury in rats with severe acute pancreatitis.
Topics: Acute Disease; Amine Oxidase (Copper-Containing); Amylases; Animals; Anti-Inflammatory Agents; Bacterial Translocation; Biomarkers; Blotting, Western; Disease Models, Animal; Endotoxins; HMGB1 Protein; Ileum; Immunohistochemistry; Intestinal Mucosa; Male; Neutrophil Infiltration; Pancreas; Pancreatitis; Permeability; Peroxidase; Pyruvates; Rats; Rats, Wistar; Severity of Illness Index; Taurocholic Acid; Time Factors; Up-Regulation | 2010 |
Therapeutic treatment with ethyl pyruvate attenuates the severity of liver injury in rats with severe acute pancreatitis.
Topics: Acute Disease; Animals; Blotting, Western; Gene Expression; HMGB1 Protein; Immunohistochemistry; Interleukin-1; Liver; Liver Diseases; Male; Malondialdehyde; NF-kappa B; Pancreas; Pancreatitis; Peroxidase; Pyruvates; Random Allocation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Severity of Illness Index; Taurocholic Acid; Tumor Necrosis Factor-alpha | 2012 |
Protective effect of ethyl pyruvate on pancreas injury in rats with severe acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; DNA; HMGB1 Protein; Male; NF-kappa B; Pancreas; Pancreatitis; Peroxidase; Pyruvates; Rats; Rats, Wistar; Survival Rate; Tumor Necrosis Factor-alpha | 2013 |
Ethyl pyruvate ameliorates acute alcohol-induced liver injury and inflammation in mice.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Bacterial Translocation; Hepatitis, Alcoholic; Intestinal Absorption; Intestinal Mucosa; Lipid Peroxidation; Liver; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Pyruvates; RNA, Messenger; Tumor Necrosis Factor-alpha | 2003 |
Ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; High Mobility Group Proteins; HMGB1 Protein; Interleukin-1beta; Interleukin-6; Kidney; Liver; Male; Pancreatitis; Pyruvates; Random Allocation; Rats; Rats, Wistar; Repressor Proteins; Taurodeoxycholic Acid; Tumor Necrosis Factor-alpha | 2007 |
[Effect of ethyl pyruvate on renal high mobility group box-1 protein expression and acute kidney injury in rats with delayed resuscitation after thermal injury].
Topics: Acute Disease; Animals; Blood Urea Nitrogen; Blotting, Western; Burns; Disease Models, Animal; HMGB1 Protein; Immunohistochemistry; Kidney; Kidney Diseases; Male; Pyruvates; Random Allocation; Rats; Rats, Wistar; Resuscitation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2007 |